Welcome to LookChem.com Sign In | Join Free   Post buying lead  Chemical Tools
Post Buying Lead

Detail of > 29925-17-5

  • MSDS Download
  • CAS Number:
  • 29925-17-5
  • Name:
  • 2-Imidazolidinone,4-[(3-butoxy-4-methoxyphenyl)methyl]-

  • Formula:
  • C15H22N2O3
  • Molecular Structure:
  • Synonyms:
  • 2-Imidazolidinone,4-(3-butoxy-4-methoxybenzyl)- (8CI);4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone;4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidone;DL-4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone;R 020-1724;Ro 20-1724;Ro20-174;Roche 20-1724;
  • Molecular Weight:
  • 278.3468
  • Density:
  • 1.099 g/cm3
  • Boiling Point:
  • 483.8 °C at 760 mmHg
  • Flash Point:
  • 246.4 °C
  • Solubility:
  • ethanol: 7 mg/mL
  • Appearance:
  • solid
  • Hazard Symbols:
  • IrritantXi
  • Risk Codes:
  • 36/37/38
  • Safety:
  • 26-36Details
Home > Products > 29925-17-5

Refine Suppliers Do you want your product ranking ahead? Know what is 'Top Seller'!

Supplier Location:
United States(2)Japan(1)United Kingdom(1)
Business Type:
Importer/Exporter(3)
Certificates:
ISO (0) Production License (0)

Page:1/1   

CAS No. 

29925-17-5 2-Imidazolidinone,4-[(3-butoxy-4-methoxyphenyl)methyl]-

RO 20-1724
United States  
  • Tel:1- (858) 452-9925
  • Address:United States

CAS No. 

29925-17-5 2-Imidazolidinone,4-[(3-butoxy-4-methoxyphenyl)methyl]-

RO 20-1724
Japan  
  • Tel:81 75 251 1723 81-75-251-1730
  • Address:Nijo Karasuma, Nakagyo-ku Kyoto 604-0855 Japan

CAS No. 

29925-17-5 2-Imidazolidinone,4-[(3-butoxy-4-methoxyphenyl)methyl]-

more information,pls contact with us!
United States  
  • Tel:1-877-452-9925
  • Address:6450 Lusk Blvd. Suite E102 San Diego, CA 92121

CAS No. 

29925-17-5 2-Imidazolidinone,4-[(3-butoxy-4-methoxyphenyl)methyl]-

more information,please contact us
United Kingdom  
  • Tel:+44 (0) 117 916 3333
  • Address:16144 Westwoods Business Park Ellisville, Missouri 63021 USA
  • Total:4 Page 1 of 1 1
  • Please post your buying leads,so that our qualified suppliers will soon contact you!
    *Required Fields

    Reference

    The ionic dependence and steroid blockade of cyclic nucleotide-induced mitogenesis in isolated rat thymic lymphocytes
    The ionic dependence and steroid blockade of cyclic nucleotide-induced mitogenesis in isolated rat thymic lymphocytes. Morgan, J. I.; Hall, A. K.; Perris, A. D. (Dep. Biol. Sci., Univ. Aston, Gosta Green/Birmingham, Engl.). J. Cyclic Nucleotide Res., 3(4), 303-14 (English) 1977. CODEN: JCNRDU. DOCUMENT TYPE: Journal CA Section: 3 (Biochemical Interactions) Cyclic AMP [60-92-4] and its dibutyryl deriv. [362-74-3], as well as cyclic GMP [7665-99-8] and its dibutyryl deriv. [32266-35-6] were mitogenic in isolated rat thymic lymphocyte cultures. These compds. elicited the response over 2 distinct concn. ranges; cyclic AMP (or its dibutyryl deriv.) showed max. effect at 10-7 and 10-13 M, while cyclic GMP was maximally effective at 10-6 and 5 ′ 10-11 M. The mitotic response to the higher concns. of nucleotides was inhibited by addn. of testosterone [58-22-0] (0.1 mg/mL) or by removal of Mg2+ from the medium. At the lower nucleotide concns., the mitotic action was inhibited by addn. of estradiol [50-28-2] (0.1 mg/mL) or removal of Ca2+. The cyclic nucleotide analogs, cyclic 2'-deoxy-AMP [1157-33-1] and cyclic adenosine 2',3'-monophosphate [634-01-5] exhibited a similar biphasic mitogenic effect with ionic dependency and steroid blockade. Ro 20-1724 [29925-17-5], a cyclic nucleotide phosphodiesterase inhibitor, was also mitogenic at 10-5-10-8 M.
    Inhibitory effects of cyclic AMP on vasopressin release from the rat neural lobe in vitro
    Inhibitory effects of cyclic AMP on vasopressin release from the rat neural lobe in vitro. Mathison, Ron; Lederis, Karl (Fac. Med., Univ. Calgary, Calgary, Alberta, Can.). Mol. Cell. Endocrinol., 9(1), 81-9 (English) 1977. CODEN: MCEND6. DOCUMENT TYPE: Journal CA Section: 3 (Biochemical Interactions) Section cross-reference(s): 2 The basal release of vasopressin [11000-17-2] from the isolated pituitary neural lobe of the rat decreased in the presence of exogenous cyclic AMP (I) [60-92-4], 8-bromo-cyclic AMP [23583-48-4], dibutyryl cyclic AMP [362-74-3], theophylline [58-55-9], SQ 20,009 [35838-58-5], and RO20-1724 [29925-17-5]. The concn.-related decrease in vasopressin release, in the presence of phosphodiesterase inhibitors, was accompanied by a progressive increase in I concn. in the neural lobe. The findings suggest a local modulation of vasopressin release from the neural lobes.

    ©2008 LookChem.com,License:ICP NO.:Zhejiang10014259

    [Hangzhou]86-571-85317600,85317603,85317620